Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2885
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03660072 | Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma | ||
| NCT04648319 | A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma | ||
| NCT06151236 | Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma | ||
| NCT00732186 | Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia | ||
| NCT00909766 | Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects | ||
| NCT04776395 | Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma | ||
| NCT06396039 | A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis | ||
| NCT00194012 | Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder | ||
| NCT02307656 | Taste Properties of Atazanavir and Cobicistat | ||
| NCT00483405 | Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer | ||
| NCT03724968 | Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression | ||
| NCT00123474 | Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML | ||
| NCT00663260 | Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment | ||
| NCT06086886 | A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants | ||
| NCT02829918 | Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers | ||
| NCT01196273 | Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up | ||
| NCT04477642 | Abatacept for Patients With COVID-19 and Respiratory Distress | ||
| NCT00035542 | A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes. | ||
| NCT00790010 | Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma | ||
| NCT01314222 | Diabetic Peripheral Neuropathic Pain (DPNP) | ||
| NCT03184870 | A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors | ||
| NCT05678283 | A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors | ||
| NCT06710470 | A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring | ||
| NCT00374179 | CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma | ||
| NCT04877288 | A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications | ||
| NCT00430027 | Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma | ||
| NCT00944905 | Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) | ||
| NCT01188278 | Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey | ||
| NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer | ||
| NCT01106534 | XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort | ||
| NCT00135421 | Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder | ||
| NCT05169684 | A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer | ||
| NCT05899738 | A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants | ||
| NCT00593944 | Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) | ||
| NCT02161406 | A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis | ||
| NCT05044533 | A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF) | ||
| NCT02477826 | An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT06585787 | A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) | ||
| NCT00324155 | Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma | ||
| NCT02846376 | Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant | ||
| NCT01142700 | A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I | ||
| NCT02632409 | An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer | ||
| NCT00959426 | A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers | ||
| NCT03456648 | Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study | ||
| NCT03667716 | COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. | ||
| NCT00099606 | Phase I (PH I) Mad Refractory Solid Tumor Study | ||
| NCT02922452 | A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects | ||
| NCT07248839 | A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment | ||
| NCT01844895 | Methotrexate-Inadequate Response Autoinjector Device Sub Study | ||
| NCT02763761 | An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo |
